The Spinal Muscular Atrophy (SMA) Carrier Detection Test is a genetic screening test that identifies whether an individual carries mutation in the SMN1 gene, which are responsible for spinal muscular atrophy. This test is performed to assess carrier status in healthy individuals, especially those with a family history or planning pregnancy. Detecting carriers is crucial for genetic counseling, understanding reproductive risks, and making informed decisions about family planning and early intervention strategies.
The test specifically examines the SMN1 gene, whose mutations are responsible for spinal muscular atrophy, to determine if an individual is a carrier.
It detects most carriers, but rare mutations may require advanced genetic sequencing or additional confirmatory tests for complete accuracy.
Yes, it is highly recommended for couples planning pregnancy to assess reproductive risks and explore options like IVF with genetic screening.
Certainly, but there is a 25% chance of having an affected child, 50% chance of a carrier, and 25% chance of a non-carrier in each pregnancy.
A negative result greatly reduces risk but cannot completely eliminate it, as rare mutations may not be detected.
Yes, results help couples decide on assisted reproductive techniques or prenatal genetic testing to reduce risk of SMA in offspring.
Yes, it is often included in expanded carrier screening panels that test for multiple genetic conditions simultaneously.
...
Didn't recieved OTP Yet? Resend OTP